| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/16/1995 | WO1994029472A3 Mengovirus as a vector for expression of foreign polypeptides |
| 02/16/1995 | WO1994029451A3 Humanised antibodies |
| 02/16/1995 | DE4401868C1 Microbial method for detecting pollutants |
| 02/16/1995 | CA2168448A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | CA2167489A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | CA2166982A1 Human calcium channel compositions and methods using them |
| 02/16/1995 | CA2166309A1 Antimicrobial proteins |
| 02/16/1995 | CA2144523A1 High molecular weight desulphatohirudin |
| 02/15/1995 | EP0638649A2 New use of alcaligenes faecalis penicillin G acylase |
| 02/15/1995 | EP0638647A1 Nucleotide sequences permitting replication and maintaining of genetic information in animal cells |
| 02/15/1995 | EP0638644A1 Receptors of interleukin-12 and antibodies |
| 02/15/1995 | EP0638587A1 Salmycins, a process for their preparation and their use as a pharmaceutical |
| 02/15/1995 | EP0638174A1 Measles virus-specific antibody detection using recombinant measles proteins. |
| 02/15/1995 | EP0638172A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF $g(b)-AMYLOID PRECURSOR PROTEIN |
| 02/15/1995 | EP0638123A1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 02/15/1995 | EP0638119A1 Chimeric receptor genes and cells transformed therewith |
| 02/15/1995 | EP0638093A1 Novel plant virus sequences |
| 02/15/1995 | EP0638088A1 Hybrid human/porcine factor viii |
| 02/15/1995 | EP0638082A1 Macrocyclic immunomodulators |
| 02/15/1995 | EP0638077A1 Chiral cyclopentene derivatives and their preparation |
| 02/15/1995 | EP0637916A1 Agricultural use of certain compounds, compositions and methods for producing said compounds |
| 02/15/1995 | EP0531372B1 A cellulase preparation comprising an endoglucanase enzyme |
| 02/15/1995 | EP0380470B1 Process for the synthesis of sugar nucleotides using recombinant-dna methods |
| 02/15/1995 | EP0377023B1 Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 02/15/1995 | CN1098743A Selection marker gene free recombinant strains: a method for obtaining them and the use of these strains |
| 02/15/1995 | CN1098742A Novel aminopeptidase, processes for the preparation of aminopeptidase and protein therefrom |
| 02/14/1995 | US5389609 Antifungal preparations, and process for making such preparations |
| 02/14/1995 | US5389540 Employing a DNA coding sequence having a (G+C) content that has been increased in the region from nucleotide 410 to the 3' end of the coding sequence relative to wild-type DNA sequence |
| 02/14/1995 | US5389539 Purification of heparinase I, II, and III from Flavobacterium heparinum |
| 02/14/1995 | US5389538 Mutant human prourokinase |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389527 DNA encoding mammalian phosphodiesterases |
| 02/14/1995 | US5389525 DNA-molecules coding for FMDH control regions and structural gene for a protein having FMDH-activity and their use thereof |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389518 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof |
| 02/14/1995 | US5389515 Isolated nucleotide sequences for identifying Neisseria gonorrhoeae |
| 02/14/1995 | US5389513 Placing sample in nutrient medium, disrupting cells, denaturing released DNA, contacting with oligonucleotide to hybridize, detecting hybrid, correlating presence with that of Listeria monocytogenes |
| 02/14/1995 | US5389368 Avirulent microbes and uses therefor |
| 02/14/1995 | CA1334394C Method for producing oligosaccharides |
| 02/14/1995 | CA1334392C Immunosuppressant agent |
| 02/14/1995 | CA1334391C Immunosuppressant compound |
| 02/14/1995 | CA1334387C Feline leukemia virus vaccine |
| 02/14/1995 | CA1334386C Method for producing hepatitis b virus proteins in yeast |
| 02/10/1995 | CA2129812A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria in which they are present, and their use |
| 02/09/1995 | WO1995004162A2 Dna sequencing enzymes |
| 02/09/1995 | WO1995004157A1 Microorganism identification method using at least two chromogens |
| 02/09/1995 | WO1995004156A1 Microorganism identification method using a medium containing added carbohydrate |
| 02/09/1995 | WO1995004154A1 Process for producing taxol and its analogues using microorganisms |
| 02/09/1995 | WO1995004151A2 Vaccine compositions containing recombinant tetc-fusion proteins |
| 02/09/1995 | WO1995004150A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 02/09/1995 | WO1995004149A1 Process for the efficient production of 7-adca via 3-(carboxyethylthio)propionyl-7-adca |
| 02/09/1995 | WO1995004139A1 Modified dna virus vectors and uses therefor |
| 02/09/1995 | WO1995004133A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | WO1995004080A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | WO1995004079A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 02/09/1995 | WO1995004076A1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 02/09/1995 | WO1995004075A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | WO1995004074A1 THE ESCHERICHIA COLI csrA GENE, PROTEIN ENCODED THEREBY, AND METHODS OF USE THEREOF |
| 02/09/1995 | WO1995004060A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
| 02/09/1995 | WO1995003831A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | WO1995003817A1 Method of treating reproductive disorders |
| 02/09/1995 | WO1995003813A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | WO1995000645A3 Process for producing relaxin |
| 02/09/1995 | WO1994029450A3 Novel, recombinantly produced spider silk analogs |
| 02/09/1995 | CA2168790A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2168647A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | CA2168471A1 Dna sequencing enzymes |
| 02/09/1995 | CA2168426A1 Recombinant vector containing a lipoprotein gene sequence expressing nucleotide sequences |
| 02/09/1995 | CA2168261A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2168008A1 Escherichia coli csra gene, protein encoded thereby, and methods of use thereof |
| 02/09/1995 | CA2168004A1 Process for the efficient production of 7-adca via 3-(carboxyethylthio)propionyl-7-adca |
| 02/09/1995 | CA2167938A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | CA2167706A1 Modified dna virus vectors and uses therefor |
| 02/09/1995 | CA2167533A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/08/1995 | EP0637630A2 Method for the biological synthesis of peptides |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637591A2 A novel expression vector for phytolacca antiviral protein |
| 02/08/1995 | EP0637337A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
| 02/08/1995 | EP0637336A1 Mn gene and protein |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637319A1 A novel anti-neoplastic cytokine |
| 02/08/1995 | EP0637318A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 02/08/1995 | EP0637244A1 A STRAIN OF $i(STREPTOMYCES AVERMITILIS) GLYCOSYLATES AVERMECTIN COMPOUNDS |
| 02/08/1995 | EP0386222B1 Process for preparing human serum albumine by fermenting a genetically engineered microorganism in the presence of a polyalkylene compound |
| 02/08/1995 | CN1098416A Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/07/1995 | USRE34851 Biosynthesis of 2 keto-L-gulonic acid |
| 02/07/1995 | US5387742 Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387673 Active fragments of fibroblast growth factor |
| 02/07/1995 | US5387670 Antibiotic, deoxymulundocandin, a process for its production and its use as medicament |
| 02/07/1995 | US5387523 Employing a biocatalyst capable of catalyzing the sulfur-specific, oxidative cleavage of organic carbon-sulfur bonds in sulfur-bearing aromatic heterocyclic molecules |
| 02/07/1995 | US5387521 Bacillus for hyperproduction of enzyme comprising enzyme structural gene linked to functional promoter sequence, two or more mutated transcriptional regulatory genes |
| 02/07/1995 | US5387519 Recombinant avipoxvirus |
| 02/07/1995 | US5387518 Alkaline protease having stability in solution with anionic surfactant, method for producing the same, use thereof and microorganism producing the same |
| 02/07/1995 | US5387516 Pure alpha-1,6-glucosidase with acidic optimum pH, high heat resistance, broad substrate specificity |
| 02/07/1995 | US5387515 Process for providing a 6-ketone from morphine or an ether derivative thereof using morphine dehydrogenase |
| 02/07/1995 | US5387513 Culture product; polylactones having at least ten carbon atoms in monomer |